Sg Americas Securities, LLC Vir Biotechnology, Inc. Transaction History

Sg Americas Securities, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$7.76 - $10.29 $54,164 - $71,824	6,980 Added 7.8%	96,431 $970,000
Q3 2023 Oct 13, 2023	BUY	$9.14 - $24.62 $817,582 - $2.2 Million	89,451 New	89,451 $838,000
Q1 2023 Apr 28, 2023	BUY	$22.26 - $30.85 $2.49 Million - $3.44 Million	111,654 Added 1675.73%	118,317 $2.75 Million
Q4 2022 Feb 02, 2023	SELL	$19.96 - $28.22 $99,480 - $140,648	-4,984 Reduced 42.79%	6,663 $169,000
Q3 2022 Oct 31, 2022	SELL	$18.26 - $31.1 $5,149 - $8,770	-282 Reduced 2.36%	11,647 $225,000
Q2 2022 Jul 29, 2022	SELL	$19.08 - $26.7 $416,363 - $582,647	-21,822 Reduced 64.66%	11,929 $304,000
Q1 2022 Apr 29, 2022	BUY	$21.19 - $40.01 $656,360 - $1.24 Million	30,975 Added 1115.81%	33,751 $868,000
Q4 2021 Feb 07, 2022	SELL	$30.97 - $54.03 $1.78 Million - $3.1 Million	-57,355 Reduced 95.38%	2,776 $116,000
Q3 2021 Nov 01, 2021	BUY	$34.9 - $54.54 $817,602 - $1.28 Million	23,427 Added 63.83%	60,131 $2.62 Million
Q2 2021 Aug 12, 2021	SELL	$38.75 - $51.0 $202,391 - $266,373	-5,223 Reduced 12.46%	36,704 $1.74 Million
Q1 2021 May 13, 2021	BUY	$26.34 - $83.07 $497,193 - $1.57 Million	18,876 Added 81.89%	41,927 $2.15 Million
Q4 2020 Feb 04, 2021	BUY	$25.51 - $43.38 $588,031 - $999,952	23,051 New	23,051 $617,000
Q3 2020 Nov 09, 2020	SELL	$28.28 - $53.6 $696,083 - $1.32 Million	-24,614 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$27.89 - $47.86 $686,484 - $1.18 Million	24,614 New	24,614 $1.01 Million

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.